ACTG2 (Gene)

Organism:

Homo sapiens

Synonyms:ACT, ACTA3, ACTE, ACTG2, ACTL3, ACTSG, ENTREZ:72, HGNC:145, MIM:102545, NM_001199893, NM_001615, NP_001186822, NP_001606, VSCM, actin gamma 2, smooth muscle

Omim:OMIM:102545

Id:69840353-d433-551a-985f-fdf4a9879743

Hgnc:HGNC:145

Entrez:72

Ensembl:ENSG00000163017

Description:actin gamma 2, smooth muscle

Analyze

CFDE DD-Knowledge Graph

The CFDE Data Distillery Knowledge Graph contains entities and relationships across the CFDE. View ACTG2's neighborhood in the knowledge graph.

Submit

Playbook Workflow Builder: Gene-Centric Workflow

View Gene-Centric information about the gene from a pre-built PWB workflow. View the workflow with ACTG2.

CFDE Gene-Centric Appyter

The CFDE Gene Centric Appyter Resolves and Displays Gene-Centric information from CFDE APIs. Execute the Appyter using ACTG2.

Submit

GDLPA Landing Pages Links

The Gene and Drug Landing Page Aggregator (GDLPA) finds links to primary and secondary source information from CFDE and other resources. Discover landing pages for ACTG2.

Submit

Playbook Workflow Builder

The Playbook Workflow Builder helps you interactively construct workflows leveraging CFDE APIs without code. Start a new workflow with ACTG2.

Results found

Linked to

	Label	Description
	GSE156648 DOT1L overexpression IMR-90 2 v 3 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE238213 dopamine 5 v 3 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE156648 DOT1L overexpression IMR-90 2 v 0 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE102505 tunicamycin 6 v 3 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE242333 sorafenib 0 v 2 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE102505 tunicamycin 1 v 3 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE218097 SOX10 overexpression glial cell 2 v 3 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE238213 dopamine 1 v 3 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE226525 GSE226527 HNRNPH2 knockout 4 v 2 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE156761 dopamine neuron 0 v 1 human up Gene Set (Entity type)	A Gene Set from LINCS

GSE156648 DOT1L overexpression IMR-90 2 v 3 human dn

Gene Set (Entity type)

A Gene Set from LINCS

GSE238213 dopamine 5 v 3 human dn

Gene Set (Entity type)

A Gene Set from LINCS

GSE156648 DOT1L overexpression IMR-90 2 v 0 human dn

Gene Set (Entity type)

A Gene Set from LINCS

GSE102505 tunicamycin 6 v 3 human dn

Gene Set (Entity type)

A Gene Set from LINCS

GSE242333 sorafenib 0 v 2 human up

Gene Set (Entity type)

A Gene Set from LINCS

GSE102505 tunicamycin 1 v 3 human dn

Gene Set (Entity type)

A Gene Set from LINCS

GSE218097 SOX10 overexpression glial cell 2 v 3 human dn

Gene Set (Entity type)

A Gene Set from LINCS

GSE238213 dopamine 1 v 3 human dn

Gene Set (Entity type)

A Gene Set from LINCS

GSE226525 GSE226527 HNRNPH2 knockout 4 v 2 human up

Gene Set (Entity type)

A Gene Set from LINCS

GSE156761 dopamine neuron 0 v 1 human up

Gene Set (Entity type)

A Gene Set from LINCS

DISPLAY PER PAGE

CFDE Workbench

Consortium

Community

Resources

@CFDE Workbench 2025

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

Consortium

Community

Resources

CFDE Workbench

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

@CFDE Workbench 2025

This repository is under review for potential modification in compliance with Administration directives.